VuCOMP to Display Advanced Computer Vision Systems at 20th Annual Mammography in Santa Fe

VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, today announced that it will be showcasing its portfolio of cutting-edge imaging products at the 20th Annual Mammography in Santa Fe: Music, Mammograms, and Mountains, August 3-7, 2015. The meeting attracts breast imaging professionals from around the country.

VuCOMP will be highlighting the latest enhancements to the M-Vu®System, as well as a works-in-progress CAD solution for 3D breast tomosynthesis.

“VuCOMP is pleased to share the latest features of our product line, as well as share advancements on our works-in-progress CAD for breast tomosynthesis solution,” said Jim Pike, President and CTO of VuCOMP.

M-Vu CAD for mammography is the first mammography CAD proven effective in an FDA-approved reader study. The latest advancements provide radiologists with a substantial reduction in false positive marks and a lower false positive rate while improving sensitivity.

In addition, 3D tomosynthesis has continued to gain widespread acceptance, and with that comes the need for a CAD solution specifically designed to analyze the vast amount of information that tomosynthesis provides. VuCOMP engineers have been working diligently on a cutting-edge solution that is designed to identify regions of interest that are consistent with breast cancer. Ultimately, providing the radiologist with another tool precisely designed for 3D tomosynthesis.

Source: http://www.vucomp.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.